Company page

Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. is a public company traded under the ticker ARCT in the American market. The company has a market capitalization of approximately $171.96 million. Arcturus focuses on developing innovative RNA medicines, leveraging its proprietary technology platform to address unmet medical needs.

ARCT:NASDAQUpdated July 20, 2026
Arcturus Therapeutics Holdings Inc. logo
Ticker
ARCT:NASDAQ
Asset type
Stock
Market cap
$172.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD